|
Market Closed -
Nasdaq
01:30:00 31/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 15.19 USD | -0.52% |
|
+9.83% | - |
| 21/09 | Attovia Therapeutics, Inc.(NasdaqGM:ATTO) added to S&P TMI Index | CI |
| 16/09 | Attovia Therapeutics, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-16-2026 10:00 AM |
| Market Cap | 69Cr 62Cr 57Cr 52Cr 97Cr 6.58TCr 99Cr 681.24Cr 273.47Cr 3.46TCr 260.24Cr 254.71Cr 11TCr | P/E 2026 * |
-5.47x | P/E 2027 * | -7.25x |
|---|---|---|---|---|---|
| Enterprise Value | 31Cr 28Cr 26Cr 23Cr 44Cr 2.99TCr 45Cr 308.95Cr 124.02Cr 1.57TCr 118.02Cr 115.51Cr 4.95TCr | EV / Sales 2026 * |
680x | EV / Sales 2027 * | - |
| Free-Float |
90.95% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ATTO | Delayed | |
CBOE
| ATTO | Real-time |
Last Transcript: Attovia Therapeutics, Inc.
| 1 day | -0.52% | ||
| 1 week | +9.83% | ||
| Current month | -11.38% | ||
| 1 month | -11.38% |
| 1 week | 13.62 |  | 16.83 |
| 1 month | 12.94 | | 18.5 |
| Current year | 12.94 | | 28 |
| 1 year | 12.94 | | 28 |
| 3 years | 12.94 | | 28 |
| 5 years | 12.94 | | 28 |
| 10 years | 12.94 | | 28 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hangjun Zhan
CTO | Chief Tech/Sci/R&D Officer | - | 16/12/2022 |
Petter Veiby
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/06/2023 |
Tao Fu
CEO | Chief Executive Officer | 54 | 01/04/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Aaron Royston
BRD | Director/Board Member | 42 | 01/06/2023 |
Tao Fu
BRD | Director/Board Member | 54 | 01/04/2023 |
James Topper
CHM | Chairman | 64 | 01/06/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 06/08/26 | Goldman Sachs & Co. LLC (Private Banking)
| Conversion | Company | 2,55,62,737 | 59.4081% | |
| 06/08/26 | Conversion | 18,65,710 | 4.3359% | |||
| 06/08/26 | Deep Track Capital LP
| Conversion | Company | 2,01,38,956 | 46.8032% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.52% | +9.83% | - | - | 69Cr | |
| -0.62% | -1.87% | +46.31% | +56.99% | 6.38TCr | |
| +0.35% | +3.20% | +14.92% | +84.55% | 5.64TCr | |
| +0.53% | +1.96% | +15.37% | +106.81% | 5.46TCr | |
| -2.81% | -4.31% | +23.50% | +50.90% | 4.41TCr | |
| -0.33% | -1.93% | +20.15% | +98.45% | 4.21TCr | |
| +0.55% | +2.31% | +224.97% | +942.56% | 4.1TCr | |
| +3.27% | +47.96% | +112.67% | +96.48% | 3.49TCr | |
| +1.22% | -1.44% | +14.89% | +47.15% | 3.28TCr | |
| +0.89% | +20.55% | -42.03% | +373.03% | 2.47TCr | |
| Average | +0.25% | +7.77% | +47.86% | +206.32% | 3.95TCr | |
| Weighted average by Cap. | +0.18% | +5.45% | +48.50% | +186.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5L 4L 4L 3L 6L 4.39Cr 7L 45.44L 18.24L 2.31Cr 17.36L 16.99L 7.29Cr | - |
| Net income | -8.34Cr -7.47Cr -6.87Cr -6.23Cr -12Cr -792.28Cr -12Cr -82Cr -33Cr -416.76Cr -31Cr -31Cr -1.31TCr | -11Cr -9.6Cr -8.83Cr -8Cr -15Cr -1.02TCr -15Cr -105.26Cr -42Cr -535.15Cr -40Cr -39Cr -1.69TCr |
| Net Debt | -38Cr -34Cr -31Cr -28Cr -53Cr -3.6TCr -54Cr -372.29Cr -149.45Cr -1.89TCr -142.22Cr -139.2Cr -5.97TCr | -29Cr -26Cr -24Cr -21Cr -40Cr -2.72TCr -41Cr -281.07Cr -112.83Cr -1.43TCr -107.37Cr -105.09Cr -4.51TCr |
Employees
44
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/26/30 | $15.19 | -0.52% | 1,46,673 |
| 29/26/29 | $15.27 | -3.35% | 4,13,809 |
| 28/26/28 | $15.80 | +5.33% | 1,74,511 |
| 27/26/27 | $15.00 | +8.07% | 4,54,269 |
| 26/26/26 | $13.88 | +0.36% | 2,24,637 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
15.19USD
Average target price
42.20USD
Spread / Average Target
+177.81%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATTO Stock
Select your edition
All financial news and data tailored to specific country editions
